Ventyx Biosciences, Inc.
Pharmaceutical Preparations · SAN DIEGO · CA
High confidence (85%)
Updated Oct 15, 2026, 12:02 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.
Latest material event: Ventyx Biosciences, Inc. received a delisting notice from its exchange (Mar 4, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Ventyx Biosciences, Inc. received a delisting notice from its exchange
Mar 4, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting. The information set forth in the Introductory Note and under Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. On the Closing Date, the Company notified the Nasdaq Global Select Market ( Nasdaq ) of the consummation of the Merger and requested that Nasdaq (i) suspend trading of the Common Stock, (ii) withdraw the Common Stock from listing on Nasdaq, and (iii) file with the SEC on Form 25 a notification of delisting and deregistration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the Exchange A…”
Ventyx Biosciences, Inc. was delisted from its exchange
Mar 4, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001851194 Ventyx Biosciences, Inc. 001-40928 12790 El Camino Real Suite 222 San Deigo CA CALIFORNIA 92130 760-407-6511 Common Stock 17 CFR 240.12d2-2(a)(3) Jennifer Fainer CDO Analyst 2026-03-04”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- SEC CIK
- 0001851194
- Website
- —
- —
- Headquarters
- SAN DIEGO, CA
- Also known as
- —
- Legal entities
- Ventyx Biosciences, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Ventyx Biosciences, Inc. — Pharmaceutical Preparations (SIC 2834) — SAN DIEGO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001851194 Ventyx Biosciences, Inc. 001-40928 12790 El Camino Real Suite 222 San Deigo CA CALIFORNIA 92130 760-407-6511 Common Stock 17 CFR 240.12d2-2(a)(3) Jennifer Fainer CDO Analyst 2026-03-04
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting. The information set forth in the Introductory Note and under Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. On the Closing Date, the Company notified the Nasdaq Global Select Market ( Nasdaq ) of the consummation of the Merger and requested that Nasdaq (i) suspend trading of the Common Stock, (ii) withdraw the Common Stock from listing on Nasdaq, and (iii) file with the SEC on Form 25 a notification of delisting and deregistration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the Exchange A…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:33 AM
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:05 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.